公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease | SHANG-CHIN HUANG ; Su H.-J; JIA-HORNG KAO ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; CHUN-JEN LIU | Gut and Liver | 40 | 32 | |
2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee M.-H.; Huang C.-F; Lai H.-C; Lin C.-Y; Dai C.-Y; CHUN-JEN LIU ; Wang J.-H; Huang J.-F; Su W.-P; HUNG-CHIH YANG ; Kee K.-M; Yeh M.-L; Chuang P.-H; SHIH-JER HSU ; Huang C.-I; JIA-HORNG KAO ; CHIEH-CHANG CHEN ; Chen S.-H; Jeng W.-J; Yang H.-I; Yuan Y; Lu S.-N; Sheen I.-S; CHEN-HUA LIU ; Peng C.-Y; Yu M.-L; Chuang W.-L; Chen C.-J. | Scientific Reports | 16 | 14 | |
2014 | Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy | TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; YUNG-MING JENG ; Cheng H.-R; CHEN-HUA LIU ; TAI-CHUNG TSENG ; THAI-YEN LING ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology | 16 | 14 | |
2015 | Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology International | 14 | 11 | |
2021 | Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients | Cheng, Huei-Ru; HUNG-CHIH YANG ; Lin, Su-Ru; Yang, Ta-Yu; Lin, You-Yu; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO | Hepatology international | 4 | 4 | |
2015 | Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping | CHEN-HUA LIU ; Liang C.-C; CHUN-JEN LIU ; Lin C.-L; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Clinical Microbiology | 59 | 55 | |
2021 | Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients | Cheng, Huei-Ru; HUNG-CHIH YANG ; Lin, Su-Ru; Yang, Ta-Yu; Lin, You-Yu; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO | Hepatology international | 0 | 0 | |
2023 | Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease | Lin, Meng-Ju; TUNG-HUNG SU ; CHIEH-CHANG CHEN ; WEI-KAI WU ; SHIH-JER HSU ; TAI-CHUNG TSENG ; SIH-HAN LIAO ; CHUN-MING HONG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; MING-SHIANG WU ; JIA-HORNG KAO | Gut pathogens | 0 | 0 | |
2020 | Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection | Tsou H.-H.; HUNG-CHIH YANG ; Hsiao C.-F; Hsiung C.A; Liu T.-W; Chuang M.-H; Wu H.-Y; Hsu Y.-T; Tsui C.-W; PEI-JER CHEN ; ANN-LII CHENG ; CHIUN HSU ; Taiwan Cooperative Oncology Group | Journal of the Formosan Medical Association | 8 | 8 | |
2014 | The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo | Lin S.-R.; HUNG-CHIH YANG ; Kuo Y.-T; CHUN-JEN LIU ; Yang T.-Y; Sung K.-C; Lin Y.-Y; HURNG-YI WANG ; Wang C.-C; Shen Y.-C; Wu F.-Y; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Molecular Therapy - Nucleic Acids | 325 | 301 | |
2023 | Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia | Lui, Grace Chung-Yan; Wong, Grace Lai-Hung; HUNG-CHIH YANG ; WANG-HUEI SHENG ; Lee, Sun Hee | HIV medicine | 0 | 0 | |
2012 | Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 129 | 115 | |
2021 | Direct comparison of biopsy techniques for hepatic malignancies | SHANG-CHIN HUANG ; JA-DER LIANG ; SHIH-JER HSU ; TZU-CHAN HONG ; HUNG-CHIH YANG ; JIA-HORNG KAO | Clinical and molecular hepatology | 12 | 9 | |
2023 | Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B | SHANG-CHIN HUANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; Lan, Ting-Yuan; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology international | 5 | 2 | |
2013 | Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion | HUNG-CHIH YANG ; CHI-LING CHEN ; Shen Y.-C; Peng C.-Y; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Chuang W.-L; Yu M.-L; Dai C.-Y; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 43 | 37 | |
2018 | Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; JYH-MING LIOU ; CHEN-HUA LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Infectious Diseases | 59 | 52 | |
2011 | Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation | Xing S; Bullen C.K; Shroff N.S; Shan L; HUNG-CHIH YANG ; Manucci J.L; Bhat S; Zhang H; Margolick J.B; Quinn T.C; Margolis D.M; Siliciano J.D; Siliciano R.F. | Journal of Virology | 169 | 155 | |
2023 | Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease | Lin, Meng-Ju; TUNG-HUNG SU ; CHIEH-CHANG CHEN ; WEI-KAI WU ; SHIH-JER HSU ; TAI-CHUNG TSENG ; SIH-HAN LIAO ; CHUN-MING HONG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; MING-SHIANG WU ; JIA-HORNG KAO | Gut pathogens | 3 | 2 | |
2021 | Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan | CHUN-MING HONG ; Lin, You-Yu; CHUN-JEN LIU ; Lai, Ya-Yun; Shiou-Hwei Yeh ; HUNG-CHIH YANG ; JIA-HORNG KAO ; SHIH-JER HSU ; Huang, Yi-Hsiang; Yang, Sheng-Shun; Kuo, Hsing-Tao; Cheng, Pin-Nan; Yu, Ming-Lung; PEI-JER CHEN | Viruses | 5 | 2 | |
2022 | Dynamics of cellular immune responses in recipients of renal allografts positive for hepatitis B surface antigen | YA-WEN YANG ; CHIEN-CHIA CHEN ; CHING-YAO YANG ; CHIH-YUAN LEE ; HUNG-CHIH YANG ; BOR-LUEN CHIANG ; YA-HUI CHUANG ; Wu, Tiffany E; HONG-SHIEE LAI ; MENG-KUN TSAI | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 1 | |